Latest filing published 14 Oct 2020 for Aimmune Therapeutics, Inc., €300k.
Stacey Denenberg Seltzer appears in our data through filings on Aimmune Therapeutics, Inc. shares, published by SEC (Form 4). The record holds 6 filings, for trades running from 6 December 2017 to 13 October 2020.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The record was last updated on 14 October 2020 with a transaction (€300k) in Aimmune Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations